We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

IMPPP:NASDAQImperial Petroleum Inc. - 8.75% Series A Cumulative Redeemable Perpetual Preferred Shares Analysis

Data as of 2026-04-10 - not real-time

$26.16

Latest Price

6/10Risk

Risk Level: Medium

Executive Summary

Imperial Petroleum (IMPPP) trades around $26.16, with the 20‑day SMA (~$26.33) comfortably above the 50‑day (~$26.13) and 200‑day (~$25.72) averages, signaling a short‑term bullish bias. However, the MACD histogram is negative and the signal line is bearish, while volume has been trending down, suggesting caution on immediate upside. The RSI sits near 48, indicating the stock is not overbought nor oversold.
Fundamentally, the company posted a staggering 95% revenue growth YoY, robust gross (44.8%) and operating (26.7%) margins, and generated $80.8M of operating cash flow against zero debt, underpinning an 8.3% dividend yield that appears sustainable given the strong cash position. Yet, trailing EPS is negative and the PE ratio is zero, reflecting earnings volatility that tempers the attractiveness of the high yield. Volatility over the past 30 days is about 16%, beta is near zero, and liquidity is thin with decreasing volume, elevating short‑term execution risk.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Proximity to support at $25.67
  • Bearish MACD histogram and decreasing volume
  • Neutral RSI indicating limited short‑term momentum

Medium Term

1–3 years
Positive
Model confidence: 8/10

Key Factors

  • Strong 95% revenue growth and healthy margins
  • High, cash‑backed dividend yield of 8.3%
  • Bullish SMA alignment and zero debt enhancing financial stability

Long Term

> 3 years
Neutral
Model confidence: 7/10

Key Factors

  • Sustainable dividend supported by ample cash reserves
  • Exposure to energy midstream demand and diversified cargo mix
  • Low financial leverage but moderate sector and liquidity risks

Key Metrics & Analysis

Financial Health

Revenue Growth95.10%
Profit Margin31.04%
ROE10.51%
ROA4.89%
P/B Ratio1.9
Op. Cash Flow$80.8M
Free Cash Flow$39.9M
Industry P/E21.9

Technical Analysis

TrendBullish
RSI48.0
Support$25.67
Resistance$26.77
MA 20$26.33
MA 50$26.13
MA 200$25.72
MACDBearish
VolumeDecreasing
Fear & Greed Index87.32

Valuation

GradeUndervalued
TypeBlend
Dividend Yield8.30%

Risk Assessment

Beta-0.07
Volatility16.17%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskHigh

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.